Recent Updates
Recently added Catalysts
MOBI Positive Sentiment

Mobia Medical to Participate in the Piper Sandler 38th Annual Healthcare Conference

Key Takeaway: Mobia Medical, Inc. will present at the Piper Sandler 38th Annual Healthcare Conference on December 1, 2026. Management will also conduct one-on-one investor meetings. The company focuses on stroke recovery, offering the FDA-approved Vivistim® Paired VNS™ System to improve motor function in stroke survivors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Mobia Medical will present at a significant healthcare conference.
  • The company is focused on stroke recovery innovations.
  • The Vivistim® Paired VNS™ System is FDA-approved and clinically validated.

Full Press Release Details

AUSTIN, Texas, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that members of management will present and host one-on-one investor meetings at the upcoming Piper Sandler 38th Annual Healthcare Conference in New York. The presentation will take place on Tuesday, December 1, 2026, at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.
Event: Piper Sandler 38th Annual Healthcare Conference Date: Tuesday, December 1, 2026 Time: 5:30 a.m. PT / 8:30 a.m. ET Webcast: https://event.webcasts.com/starthere.jsp?ei=1783629&tp_key=efbad274e1
A live and archived version of the presentation will be available via the News & Events page of the investor section of Mobia Medical’s website.

About Mobia Medical, Inc.

Mobia Medical, Inc. is a medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.

Media Inquiries Contact

Frequently Asked Questions

When will Mobia Medical present at the conference?

Mobia Medical will present on December 1, 2026.

What is the focus of Mobia Medical?

The company focuses on stroke recovery for survivors with motor impairments.

What is the Vivistim® Paired VNS™ System?

It is an FDA-approved solution for improving upper limb function in stroke survivors.

Where can I watch the presentation?

The presentation will be available on Mobia Medical's investor website.

Last updated: Nov 17, 2026